Your session is about to expire
← Back to Search
MyCancerGene App for Cancer Genetic Testing Outcomes (MyCancerGene Trial)
MyCancerGene Trial Summary
This trial will test whether a patient-centered genetic app can increase understanding of, and affective and behavioral responses to, genetic testing. The study hypothesis is that the intervention will be associated with increases in knowledge, decreases in distress, increases in communication with relatives and health care providers, and increases in performance of risk reducing health behaviors.
MyCancerGene Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMyCancerGene Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MyCancerGene Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can speak English.You must have access to the internet and/or a mobile phone.I have undergone genetic counseling and testing for hereditary cancer within the last 60 days.I am either male or female.I am 18 years old or older.I speak English.I have undergone genetic counseling and testing for cancer within the last 60 days.I am either male or female.I am 18 years old or older.
- Group 1: Intervention Group
- Group 2: Usual Care Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the intended outcomes of this research?
"This trial has two primary objectives: to evaluate patients using the KnowGene Scale, and to measure changes in uncertainty with the Multi-dimensional Impact of Cancer Risk Assessment Questionnaire (MICRA). Secondary evaluation includes assessing shifts in perceived risk, timeline and utility through quantitative scales as well as Yes/No responses for dietary guidelines. The study will span a period of 18 months from baseline."
Are there any vacancies available for participants in this trial?
"According to details provided on clinicaltrials.gov, this study is currently enrolling participants. Initially published on May 3rd 2021, the trial was most recently updated July 11th 2022."
How many participants is the medical trial accepting at this time?
"Affirmative, clinicaltrials.gov has evidence that this research trial is actively recruiting participants. It was initially posted on May 3rd 2021 and the last update occured on July 11th 2022. 400 individuals must be admitted at a single medical centre to meet their recruitment goals."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger